Leishmania plasma membrane lipids

Leishmania plasma membrane lipids are essential structural and functional constituents of the Leishmania parasite, crucial for its survival and virulence across its complex life cycle. The membrane is characterized by a unique lipid profile, notably containing ergosterol as the primary sterol instead of the cholesterol found in mammalian cells, and specialized glycoconjugates like lipophosphoglycan (LPG) (Source: https://www.nature.com/articles/nrmicro1108). These lipids maintain membrane fluidity, provide a protective barrier against the host's immune system, and facilitate the invasion of host macrophages. Because of the biochemical distinctions between parasite and host membranes, these lipids are primary targets for several antileishmanial drugs. For instance, Amphotericin B selectively binds to ergosterol, forming aqueous pores that cause lethal ion imbalance (Source: https://pubmed.ncbi.nlm.nih.gov/23439522/), while Miltefosine acts as a phospholipid analog that disrupts lipid metabolism and intracellular signaling (Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436061/). Targeting these lipid components remains a cornerstone of leishmaniasis treatment, though challenges such as drug toxicity and emerging resistance necessitate ongoing research into the leishmanial lipidome.

Other names

Leishmanial membrane lipidsLeishmania cell membrane lipidsLeishmania surface lipidsLeishmania sterols and phospholipids

Amphotericin B binds to membrane ergosterol to form aqueous pores, leading to ion leakage and cell death; Miltefosine acts as an alkylphosphocholine analog that interferes with phospholipid metabolism and cell signaling pathways.